Scientists Find Intriguing Link Between Ozempic and Violent Behavior
A Rutgers University study examined survey data and found that people currently using GLP-1 drugs such as Ozempic showed a weaker link between impulsivity, alcohol use, and violent behavior. The researchers reported that the association between impulsivity and violence was about 62% weaker and the link between alcohol use and violence about 52% weaker among current users. The authors emphasize that the observational design cannot prove causation and call for further longitudinal research.
- ▪The analysis used data from a nationally representative survey of 7,521 U.S. adults, focusing on 821 individuals who had ever taken a GLP-1 medication, including 597 current users.
- ▪Among current GLP-1 users, the relationship between impulsivity and violent behavior was roughly 62% weaker, and the relationship between alcohol use and violence was about 52% weaker compared to former users.
- ▪The study is cross‑sectional and observational, so it cannot establish a cause‑and‑effect link between GLP‑1 use and reduced violent behavior.
- ▪Researchers noted that GLP‑1 drugs have been shown in other studies to affect reward processing, cravings for alcohol and other substances, and stress regulation, which may underlie the observed behavioral effects.
Gizmodo files mainly under tech. We currently carry 693 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Gizmodo |
| Canonical URL | https://gizmodo.com/scientists-find-intriguing-link-between-ozempic-and-violent-behavior-2000772629 |
| Publication time | Wed, 17 Jun 2026 07:01:32 +0000 |
| Retrieval time | 2026-06-17T07:04:38.814Z |
| Last seen | 2026-06-17T07:04:38.814Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | AGk5VcXx7JNU |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
It’s become a running joke at this point that GLP-1 drugs like semaglutide (the active ingredient in Ozempic and Wegovy) can help with almost everything under the Sun, not just weight loss. A study out today now suggests GLP-1s might even have the potential to curb people’s violent tendencies. Scientists at Rutgers University examined nationally representative survey data that compared former and current GLP-1 users. In people currently taking GLP-1s, they found, the link between being impulsive and being more prone to violence was noticeably weaker. Though the team’s findings are far from certain proof that GLP-1s can reduce violent behavior, they do warrant follow-up research, the authors say.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Gizmodo.
Discussion
0 commentsMore from Gizmodo
